Podcast on The Human Microbiome: Health and Disease

Kapitoly

Úvod do mikrobiomu

K čemu je to dobré?

Jak se mikrobiom zkoumá?

Projekt lidského mikrobiomu

Mikrobiom a zdraví

How We Study Microbes

A Gut Census

A Genetic Jigsaw Puzzle

Reads, Long and Short

The Cell's Exhaust

The Molecule Zapper

Weighing the Molecules

Bacterial Sabotage

A Criminal Signature

The Smoking Gun

An Epidemic in the Gut

Leaky Gut, Big Problems

From Leaky Gut to IBD

A Global Tummy Ache

When the Body Fails

Causes and Fixes

Přepis

Chloe: …počkat, takže celá ta věc je vlastně jako náš „druhý genom“? To je neuvěřitelné.

Ryan: Přesně tak! A je to genom, který není ani lidský. V podstatě máme v sobě a na sobě celou zoo mikroorganismů, která nám pomáhá řídit spoustu věcí.

Chloe: Dobře, tohle jsem vůbec netušila – a myslím, že to musí slyšet každý. Posloucháte Studyfi Podcast.

Ryan: Takže, abychom to uvedli na pravou míru. Lidský mikrobiom je soubor všech mikroorganismů – bakterií, hub, virů, dokonce i archeí – které žijí na našem těle a v něm.

Chloe: Nejsou to jen střeva, že? Jsou všude?

Ryan: Všude. Na kůži, v ústech, v zažívacím traktu... Můžete si naše tělo představit jako takový „superorganismus“, který je směsicí lidských a mikrobiálních genů.

Chloe: Dobře, takže máme spoustu malých spolubydlících. Co pro nás dělají? Platí nájem?

Ryan: V jistém smyslu ano! Jsou naprosto klíčoví. Pomáhají nám trávit potravu, kterou bychom sami nezvládli, třeba určité typy rostlinné vlákniny.

Chloe: Takže bez nich bychom z jídla nedostali tolik živin?

Ryan: Přesně. Také pro nás vyrábějí nezbytné vitamíny a aminokyseliny. A co je super důležité – trénují náš imunitní systém a tvoří přirozenou bariéru proti patogenům.

Chloe: Fungují tedy jako taková osobní ochranka?

Ryan: Přesně tak. Vytlačují špatné mikroby a dokonce produkují látky, které je ničí. Bez nich by byl náš imunitní systém zmatený a slabý.

Chloe: Jak to všechno vůbec víme? Můžeme si je prostě vypěstovat v laboratoři a podívat se na ně?

Ryan: To je právě ten problém. Většinu z nich, méně než jedno procento, v laboratorních podmínkách vůbec nedokážeme kultivovat. Jsou příliš vybíraví.

Chloe: Aha, takže klasická mikrobiologie tady moc nepomůže.

Ryan: Moc ne. Proto se dnes používá genetická analýza. Místo pěstování jednotlivých bakterií analyzujeme jejich DNA přímo ze vzorku. Tomu se říká metagenomika.

Chloe: Zkoumáme tedy genetickou informaci celé komunity najednou.

Ryan: Přesně. Je to jako číst si v knize receptů celého ekosystému, abychom pochopili, co všechno umí uvařit, aniž bychom museli každého kuchaře zvlášť chytat.

Chloe: Slyšela jsem o Projektu lidského mikrobiomu. To s tím souvisí, že?

Ryan: Ano, to byl obrovský projekt, který odstartoval v roce 2007. Vzali vzorky od 242 zdravých lidí z různých míst na těle, aby zmapovali, jak vypadá „normální“ mikrobiom.

Chloe: A co zjistili? Máme všichni stejné broučky?

Ryan: A tady je to zajímavé – vůbec ne! Složení druhů se mezi lidmi hodně liší. Ale... a to je klíčové... metabolické funkce, které ta komunita vykonává, jsou u zdravých lidí velmi podobné.

Chloe: Takže nezáleží tolik na tom, KDO tam bydlí, ale spíš na tom, CO DĚLÁ?

Ryan: Bingo! Dokud je práce hotová – trávení, výroba vitamínů – je jedno, jestli ji dělá bakterie A nebo bakterie B.

Chloe: A co se stane, když ta práce hotová není? Souvisí to s nemocemi?

Ryan: Rozhodně. Dnes už víme, že narušený mikrobiom souvisí s celou řadou problémů – od kožních onemocnění jako akné, přes zánětlivá onemocnění střev, až po obezitu.

Chloe: Takže lidé s obezitou mají jiný mikrobiom?

Ryan: Často ano. Studie ukázaly, že lidé s nižší rozmanitostí mikrobů ve střevech mají větší sklon k obezitě a inzulínové rezistenci.

Chloe: To dává smysl. A co naopak? Může nám mikrobiom v něčem pomoci, třeba ve sportu?

Ryan: Skvělá otázka! Ano! Zjistilo se, že vrcholoví sportovci mají v mikrobiomu často více určitých typů archeí, jako je *Methanobrevibacter smithii*. Tyto mikroorganismy pomáhají efektivněji zpracovávat odpadní produkty metabolismu a získávat z potravy více energie.

Chloe: Takže správní mikrobi mohou být v podstatě legální doping.

Ryan: Přesně tak! Je to fascinující svět, který teprve začínáme objevovat.

Chloe: It's incredible to think about. But it raises a big question for me, Ryan. How on earth do scientists actually study this invisible world inside us? You can't just... send a tiny camera crew down there.

Ryan: Not yet, anyway! That would be amazing. No, the process is really clever. It starts with sampling. Researchers, like in the big Human Microbiome Project, took samples from all over the body.

Chloe: All over? Like where?

Ryan: Oh, everywhere! Skin, like behind your ear and the crook of your elbow. The entire oral cavity—your tongue, your gums, your teeth. And of course, the gut, which we usually study from stool samples.

Chloe: Okay, so you've got the samples. Then what? How do you figure out who's in there?

Ryan: Great question. That's the first major goal: to find out which organisms are present. For that, we use a technique that focuses on one specific gene, the 16S rRNA gene.

Chloe: That sounds complicated.

Ryan: It's not as bad as it sounds! Think of it this way—that gene is like a unique barcode or a name tag for most microbes. We sequence just that one gene from all the microbes in a sample.

Chloe: And that tells you who you're looking at? Like a microbial census?

Ryan: Exactly! It gives us a list of all the species present and how many of each there are. It’s the

Chloe: So it's like a roll call for your gut! Okay, so once you have this microbial census, what kind of things have we learned from it?

Ryan: So much! A really cool study by Zhou and his team, published in Genome Biology, did just this. They analyzed stool microbiomes from hundreds of people to see who was there.

Chloe: What kinds of people were they looking at?

Ryan: All sorts! They compared men and women, people from different cities like St. Louis and Houston, and even different origins, like Hispanic and Latino groups.

Chloe: And what about health factors? Did they look at things like weight?

Ryan: Exactly. They specifically looked at Body Mass Index, or BMI. They grouped people with a BMI below 25, those between 25 and 30, and those with a BMI over 30, which is in the obesity range.

Chloe: So they're basically mapping out who lives where, inside of us. What did they find? Was everyone's gut just a random jumble?

Ryan: Not at all! They found these distinct community types. Think of them like different neighborhoods inside the gut. One type was dominated by a bacteria called Bacteroides.

Chloe: Okay, the Bacteroides neighborhood. What were the others?

Ryan: Another was run by a group called Prevotella, and the third major type was predominated by Ruminococci. It's like finding out your gut is either a bustling city or a quiet suburb.

Chloe: I love that. So your BMI or where you live could help determine which microbial "neighborhood" you belong to?

Ryan: That's the key takeaway! It showed clear links between our lifestyle, our bodies, and the specific microbes that call us home. Which naturally leads to the next question: how do these tiny residents actually impact our health?

Chloe: Exactly! I mean, with hundreds or even thousands of different species in there, how do you even begin to figure out who's doing what?

Ryan: That's where it gets really cool. We use a technique called metagenomics. It's a way to study the genetic material from a whole community of organisms all at once.

Chloe: Metagenomics... okay, break that down for me.

Ryan: Think of it this way. Instead of trying to grow each individual microbe in a petri dish—which is super difficult—we just take a sample, say from the gut, and sequence all the DNA in it.

Chloe: So you're not looking at one bacterium's DNA, but everyone's DNA jumbled together?

Ryan: Precisely! It's like taking a thousand different books, shredding them all into tiny strips of paper, and then trying to piece them back together to figure out what the original stories were.

Chloe: Okay, that sounds impossibly difficult. And I thought my jigsaw puzzles were hard.

Ryan: It is! But that's the challenge. The first step is called shotgun sequencing, where we literally blast all the DNA into millions of tiny fragments.

Chloe: So how much information are we talking about from one of these... DNA explosions?

Ryan: A massive amount. A single sequencing run can generate gigabases of data. That's billions of DNA letters. It’s an enormous text file of genetic puzzle pieces.

Chloe: Billions! So, after you shred the books, how do you read the little paper strips to put them back together?

Ryan: Great question. Each tiny fragment we sequence is called a 'read'. And the length of that read is super important. Some older techniques gave us really short reads... maybe just 150 letters long.

Chloe: That's like trying to rebuild a novel from two-word scraps. It sounds awful.

Ryan: It was! Here's the key takeaway: the longer the read, the easier it is to assemble the puzzle. Modern techniques give us much longer reads, sometimes thousands of letters long.

Chloe: Ah, so you're getting whole paragraphs instead of just a few words. That makes way more sense.

Ryan: Exactly. Longer reads have fewer overlaps with other random bits of DNA, so the computer can confidently stitch them together to rebuild the original genomes. It's the difference between a 10,000-piece puzzle of blue sky and a 100-piece puzzle with a big red barn on it.

Chloe: I'll take the red barn puzzle any day. Okay, so once the puzzle is assembled and you have these complete genomes, what do you do with them? How do you figure out their function?

Ryan: That's a fantastic question. Knowing the genome is like having the blueprint for a car. But to know what the car is *actually doing*... you have to look at its exhaust.

Chloe: The exhaust? You mean the byproducts?

Ryan: Exactly! In a cell, those byproducts are called metabolites. Studying them is called metabolomics, and it gives us a real-time snapshot of the cell's activity.

Chloe: Okay, so how do you even measure these tiny metabolites?

Ryan: With a really cool technique. One method is called MALDI. It stands for Matrix-Assisted Laser Desorption/Ionization.

Chloe: MALDI? Sounds like a nickname.

Ryan: It does! We mix our sample into a special matrix and then… we zap it with a laser!

Chloe: You zap it with a laser? That sounds very sci-fi.

Ryan: It is! The laser gently lifts the molecules into the air as charged ions, but it does it so gently that they don't shatter into a million pieces.

Chloe: So they're floating in the air as ions. Now what?

Ryan: Now we send them into a mass spectrometer. Think of it like a racetrack for molecules with a giant magnet on the side.

Chloe: A magnetic racetrack?

Ryan: Yup. The magnet deflects the ions. Lighter ions get whipped around the curve really sharply, while heavier ones take a wider turn.

Chloe: Ah, so by seeing how much they bend, you can figure out their mass.

Ryan: Precisely! We measure their mass-to-charge ratio. That tells us what the molecules are, and it links the genetic code to what the cell is actually doing.

Chloe: So you get the blueprint with genomics, then use metabolomics—with lasers and magnetic racetracks—to see what the factory is actually producing. That's amazing.

Ryan: Exactly. But what's really fascinating—and a bit scary—is when things in that factory go wrong. And sometimes, the saboteurs aren't viruses, but bacteria from our own microbiome.

Chloe: You mean the so-called "good bacteria" in our gut? How can they cause cancer?

Ryan: Well, some aren't so good. Think of it this way: certain bacteria produce toxins that can directly damage our cell's DNA. It's like they're equipped with tiny molecular scissors.

Chloe: Scissors? What kind of bacteria are we talking about?

Ryan: A specific group of E. coli, for example, produces a toxin called colibactin. It's notorious for causing double-stranded DNA breaks... basically, it snaps the genetic blueprint in half.

Chloe: That sounds incredibly dangerous. So how do we know this specific toxin is the culprit in human cancers?

Ryan: Great question. Here's the really clever part. Scientists found that colibactin doesn't just break DNA randomly. It leaves behind a very specific type of mutational signature.

Chloe: A signature? Like a criminal leaving a calling card at the crime scene?

Ryan: Exactly! It's like CSI: Microbiome. This toxin causes a unique pattern, like deleting a specific letter—thymine—over and over again in a DNA sequence.

Chloe: Okay, so they found the signature in a lab. But did they find it in actual patients?

Ryan: They did. Researchers analyzed the genomes from thousands of colorectal cancer tumors. And in a subset of them, they found that exact same colibactin signature. It was the smoking gun.

Chloe: Wow. So the bacteria in our gut could literally be leaving a footprint that leads to cancer. That's... mind-blowing.

Ryan: It completely changes how we think about the causes of diseases like colorectal cancer. It's a huge issue, with around 7,700 new cases diagnosed each year just in the Czech Republic.

Chloe: So what makes the gut vulnerable to these bacterial saboteurs in the first place? Does it have something to do with inflammation?

Ryan: You're spot on, Chloe. Inflammation is a huge piece of the puzzle. It's all connected to this wider issue of metabolic disease, with obesity being a major one.

Chloe: We hear about the obesity epidemic all the time. How significant is it really?

Ryan: It's staggering. Its prevalence has more than tripled globally since 1975. We often blame high-calorie diets and sedentary lifestyles, which are definitely big contributors.

Chloe: The classic 'eat less, move more' advice.

Ryan: Exactly. But here’s the surprising part... that's not the whole story. Research shows the gut microbiomes of obese individuals are structurally and functionally distinct from those of leaner people.

Chloe: So it's not just about willpower? There’s a whole ecosystem of bacteria influencing our weight?

Ryan: Precisely! And that completely changes the game. It suggests we could potentially target the microbiome to develop new treatments for obesity.

Chloe: So how does a 'bad' microbiome actually contribute to weight gain? Is it just making us absorb more calories?

Ryan: That's part of it, but it gets more interesting. Think of your gut lining as a very tight security fence. A healthy microbiome keeps that fence strong.

Chloe: A well-guarded fortress!

Ryan: Exactly! But an unhealthy microbiome can weaken that fence, creating what scientists call a 'leaky gut'.

Chloe: Uh oh. What escapes through a leaky gut fence?

Ryan: Inflammatory molecules, like something called Lipopolysaccharide, or LPS. When LPS leaks into your bloodstream, it triggers low-grade, chronic inflammation all over your body.

Chloe: And that inflammation is a key driver of metabolic problems like obesity. It all connects back! It's like the bacteria are leaving the security gate wide open for troublemakers.

Ryan: Exactly. And when that low-grade inflammation becomes chronic and starts attacking your own gut... you get into some serious conditions. One of the big ones is Inflammatory Bowel Disease, or IBD.

Chloe: I've heard of that. It's not just one thing, right? It's a group of conditions?

Ryan: That's right. Think of it as an umbrella term for autoimmune chronic inflammations that can happen anywhere in the digestive tract, from the oesophagus all the way down.

Chloe: So how widespread is this? Is IBD a problem everywhere, or is it concentrated in certain areas?

Ryan: Great question. A 2011 study by Cosnes and his team created a global map that shows exactly that. It's color-coded to show how common IBD is around the world.

Chloe: Let me guess, like a traffic light? Red means stop... or in this case, a really high incidence?

Ryan: You nailed it. The red areas have an annual incidence greater than 10 out of 100,000 people. You see this mostly in North America and Europe.

Chloe: So, the places with the most drive-thrus. What a shocker.

Ryan: It's a correlation that's hard to ignore. Then orange is a medium incidence, and green is low, under 4 per 100,000.

Chloe: What about the yellow spots? Is that for countries that are just... feeling a little cautious?

Ryan: Almost! Yellow means the incidence is currently low, but it's increasing continuously. It's a major warning sign for those regions.

Chloe: So the takeaway here is that this isn't random. There are clear patterns, which really points back to our environment and lifestyle.

Ryan: Exactly. And that leads us perfectly into our next topic: what specific factors are actually pulling the trigger?

Chloe: Okay, so environmental factors can pull the trigger. But what happens when the problem is... internal? Like, when our own immune system just isn't built right from the start?

Ryan: That's a huge area of study, and it brings us to immunodeficiency. A classic example is Common Variable Immunodeficiency, or CVID. It affects up to 1 in 25,000 people worldwide.

Chloe: CVID. What does that actually mean for a person?

Ryan: It means their body doesn't produce enough antibodies—specifically IgG, IgM, and IgA. Think of them as your immune system's front-line soldiers. Without them, you get a lot of recurrent infections.

Chloe: So it's not just getting more colds. What kind of problems does this cause?

Ryan: It's much more serious. We're talking chronic lung disease and severe inflammation in the gastrointestinal tract. It's a constant battle.

Chloe: And what's the root cause? Is it genetic?

Ryan: Exactly. It's often linked to deletions in genes that create crucial cell surface proteins. It’s like the body’s security system is missing the blueprints for its own guards.

Chloe: So the guards can't recognize who to let in and who to kick out!

Ryan: Precisely! And sadly, treatments are limited. The main one is lifelong immunoglobulin replacement therapy. It’s a constant management game.

Chloe: Wow. So to recap, our environment, our lifestyle, and even our own genetics play a huge role in our immunity. It's a complex, interconnected system.

Ryan: It really is. The key takeaway is that understanding these factors is the first step to protecting ourselves. Thanks for listening to Studyfi Podcast!

Chloe: And thank you, Ryan! We'll see you all next time.